Jump to main content
US EPA
United States Environmental Protection Agency
Search
Search
Main menu
Environmental Topics
Laws & Regulations
About EPA
Health & Environmental Research Online (HERO)
Contact Us
Print
Feedback
Export to File
Search:
This record has one attached file:
Add More Files
Attach File(s):
Display Name for File*:
Save
Citation
Tags
HERO ID
7433291
Reference Type
Journal Article
Title
Further experience with mebendazole in the treatment of symptomatic trichuriasis in children
Author(s)
Scragg, JN; Proctor, EM; ,
Year
1978
Is Peer Reviewed?
Yes
Journal
American Journal of Tropical Medicine and Hygiene
ISSN:
0002-9637
EISSN:
1476-1645
Volume
27
Issue
2 I
Page Numbers
255-257
Language
English
PMID
646017
DOI
10.4269/ajtmh.1978.27.255
URL
https://ajtmh.org/doi/10.4269/ajtmh.1978.27.255
Exit
Abstract
Mebendazole (methyl-5-benzoylbenzimidazole-2-carbamate: Vermox), a broad spectrum anthelmintic, cured 22 (88%) children with symptomatic trichuriasis when given as a single 6-day course in a dosage of 100 mg twice daily. A further 3 (12%) were cured after a repeat 6-day course of therapy. Thus complete parasite eradication was achieved in all. The administration of an antidiarrheal agent, loperamide hydrochloride (Imodium), appeared to enhance the efficacy of mebendazole. Both drugs were well tolerated and completely free of any toxic effects.
Keywords
loperamide; mebendazole; drug response; drug therapy; geographic distribution; nematode; oral drug administration; school child; South Africa; therapy; trichuriasis; Trichuris
Tags
Other
•
Harmful Algal Blooms- Health Effects
April 2021 Literature Search
PubMed
Scopus
Saxitoxins
PubMed
Home
Learn about HERO
Using HERO
Search HERO
Projects in HERO
Risk Assessment
Transparency & Integrity